If you didn’t know there was an industry attempting de-extinction, now you do. Colossal Biosciences is one of the largest companies working, and they recently announced a breakthrough in stem cell research, which brings them closer to their major goal, of bringing the woolly mammoth back to life.
Able to turn induced pluripotent stem cells (iPSC) from engineered elephant cells into an embryonic state, the team at Colossal are making big strides towards their ambitious goals of bringing the first woolly mammoth babies into the world by the year 2028.
It’s a hugely difficult and controversial project, and one that we find fascinating for a number of reasons. What’s your take? Is de-extinction an exciting step, or a possibly dangerous one?
Read more about the complex process on Colossal’s website.



Colossal Biosciences has a long list of species it wants to bring back to life, including the Dodo bird, and the Thylacine, also known as the Tasmanian Tiger.
“Engineering a woolly mammoth embryo no longer poses a huge challenge, Hysolli said, but birthing a healthy calf will take more time and work. The team is still researching alternative methods to generate elephant iPSCs and maturing the ones they have newly developed. The iPSCs breakthrough, which will be published on the preprint database bioRxiv, has yet to be peer-reviewed.”














